Inspiren

Value-based virtual care platform for expectant mothers and families with newborns: multidisciplinary clinical teams (obstetricians, midwives, doulas, care coordinators) combined with predictive analytics-driven risk identification; customers are health insurers, employers and Medicaid programs; reduces high-cost events such as preterm births, emergency room visits and NICU admissions.

Series C · $171M · 2026-01 · Valuation $1.7B

Building an AI care platform for senior living and skilled nursing that helps care teams identify risks earlier and reduce health deterioration

Series C · $124M · 2026-03

AI-driven home caregiver training and certification, and in-home care services

Series C · $117M · 2026-10

Ultrasound brain-computer interface for whole-brain read/write, treating chronic pain, stroke rehabilitation, PTSD and other neurological conditions

Angel · $80M · 2026-07

Drug developer using genetics and AI to discover first-in-class targets

Series D+ · $55M · 2026-07

AI clinical assistant for European healthcare providers: pre-visit summaries, real-time consultation transcription, and automatic post-visit generation of medical records and diagnostic codes

Series B · $160M · 2026-09

AI voice documentation assistant for frontline nursing that generates standardized nursing records automatically

Series A · $59M · 2025-11

AI coordination of hospital discharge and follow-up care

$44M · 2026-02

AI ambient documentation and clinical agent for clinicians (AI Care Partner)

Series C · $437M · 2026-09 · Valuation $900M

Health subscription membership for individuals and businesses (unlimited consultations, free testing), with a company-operated network of hospitals and clinics and accompanying health insurance.

Series B · $120M · 2026-10 · Valuation $300M

Urine microRNA plus AI early cancer detection service (miSignal) and software medical device development for pancreatic cancer diagnosis

Series D+ · $88M · 2026-08